 |
 |
ON NOVEMBER 21 I SPOTTED THIS ON THE FINANCIAL NEW WIRE; H. LUNDBECK A/S AND CENTAUR PHARMACEUTICALS INC., JOIN TO DEVELOP PHARMACEUTICALS FOR PARKINSON'S DISEASE Copenhagen and Sunnyvale, Calif. Nov. 20 "(these two companies) announced today that they have entered into agreement to co-develop new drugs to treat P>D>"...this will be based on Centaur's proprietary NRT technology... LUNDBECK is one of Europe's most successful CNS (?) companies. It is a research pharmaceutical company. Company focases on treadment of deseases of the central nervous system. 9'95 sales $320Million CENTAUR discovers and develops product to treat diseases of aging. PD, Alzheimer's, cerebral stroke, retinal disorders and other similiar diseases. (The above information has been taken from the press release and condenesed by myself) and the search continues...... Chuck, CG/Joyce/52/13y